In 2015, a trade group for major drug distributors planned to shift blame for the opioid epidemic to pharmacists, doctors and their patients. That's according to a memo mentioned in the ongoing trial in West Virginia that aims to hold some of the nation's largest drug distributors (McKesson, AmerisourceBergen, and Cardinal Health) financially liable for the opioid epidemic.
The memo was "sent to a senior executive at that trade group, the Healthcare Distribution Alliance, that bemoaned 'imbalanced' coverage by reporters at local papers" and offered strategies for shunting the blame elsewhere, Lucas Manfield reports for Mountain State Spotlight.The prosecutors "have argued that the drug distributors were well aware that they were fueling an epidemic of opioid addiction, but were more concerned with their bottom line than restricting the flow of opioids," Manfield reports. "Meanwhile, defense attorneys have argued that drug distributors are just middlemen and that their actions did not cause the opioid crisis." Though it's unclear whether any of the defendants acted on specific advice in the memo, the prosecutors argued that it illustrates the companies' willingness to prioritize profits over patient safety.
from The Rural Blog https://ift.tt/3iiFvi2 Opioid trial update: drug distributor trade group memo showed plans to shift blame for opioid epidemic to providers, patients - Entrepreneur Generations
0 Response to "Opioid trial update: drug distributor trade group memo showed plans to shift blame for opioid epidemic to providers, patients - Entrepreneur Generations"
Post a Comment